LYOPHILIZED PEPTIDE

Retatrutide

Triple-agonist research peptide active at GLP-1, GIP and glucagon receptors.

Format

Lyophilized powder, single-use vial

Availability

IN STOCK

FOR RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION

Bundle

Total

$65

VIEW CART

STRUCTURAL DESCRIPTION

Retatrutide is an investigational synthetic peptide reported in the literature as a triple receptor agonist (GLP-1 / GIP / glucagon). Used in preclinical metabolic-signalling research.

MECHANISM IN RESEARCH CONTEXT

Engages all three incretin/glucagon receptor families; studied in metabolic-pharmacology and receptor-crosstalk contexts.

RELEVANT LITERATURE

Selected references

Provided for research context only. Inclusion does not imply any claim about the product or its use.

Triple hormone receptor agonist retatrutide for obesity (Phase 2)
Jastreboff et al., NEJM, 2023

More from this category

BPC-157

Synthetic pentadecapeptide fragment derived from a gastric protein sequence.

TB-500 (Thymosin β-4 Fragment)

Synthetic fragment of the naturally occurring Thymosin Beta-4 protein.

GHK-Cu

Naturally occurring copper-binding tripeptide (Glycyl-L-Histidyl-L-Lysine + Cu²⁺).